Immunology Insights Into Cardiac Allograft Rejection

被引：3
|
作者：
Savasta, Marcello [1 ]
Lentini, Salvatore [1 ]
机构：
[1] Univ Messina, Policlin G Martino Univ Hosp, Cardiovasc & Thorac Dept, I-98100 Messina, Italy
来源：
REVIEWS IN CARDIOVASCULAR MEDICINE | 2011年 / 12卷 / 02期
关键词：
Immunology; Heart transplantation; Surgery; Complications; Rejection; Coronary artery pathology; Pharmacology; Physiology; HEART-TRANSPLANT RECIPIENTS; ALEMTUZUMAB CAMPATH-1H; INTERNATIONAL-SOCIETY; LUNG-TRANSPLANTATION; CYCLOSPORINE-A; TACROLIMUS; TOLERANCE; RETRANSPLANTATION; VASCULOPATHY; MULTICENTER;
D O I：
10.3909/ricm0562
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Despite long-term complications from chronic immunosuppressive therapy, the phenomenon of chronic rejection is still a limitation in cardiac allograft recipients. In this review, starting from basic immunologic concepts, we analyze the mechanisms involved in rejection following heart transplantation, with particular emphasis on chronic rejection manifested as cardiac allograft vasculopathy (CAV). Etiopathogenesis of CAV and diagnostic imaging studies are also discussed. (C) 2011 MedReviews (R), LLC
引用
收藏
页码：E68 / E76
页数：9
相关论文
共 50 条
  • [41] Immunomodulatory effects of mesenchymal stem cells for the treatment of cardiac allograft rejection
    Wu, Zhichao
    Liang, Jialiang
    Huang, Wei
    Jiang, Lin
    Paul, Christian
    Gao, Xiang
    Alam, Perwez
    Kanisicak, Onur
    Xu, Meifeng
    Wang, Yigang
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (07) : 851 - 860
  • [42] Expression of extra domain A containing fibronectin in chronic cardiac allograft rejection
    Franz, Marcus
    Berndt, Alexander
    Gruen, Katja
    Richter, Petra
    Kosmehl, Hartwig
    Neri, Dario
    Gummert, Jan
    Figulla, Hans R.
    Brehm, Bernhard R.
    Renner, Andre
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (01) : 86 - 94
  • [43] Bradycardia and syncope as a presentation of cardiac allograft rejection involving the conducting system
    Knight, Carrie S.
    Tallaj, Jose A.
    Rayburn, Barry K.
    Pamboukian, Salpy V.
    Bourge, Robert
    Kirklin, James K.
    McGiffin, David
    Litovsky, Silvio H.
    CARDIOVASCULAR PATHOLOGY, 2010, 19 (02) : 117 - 120
  • [44] Recent advances in the role of mammalian target of rapamycin inhibitors on cardiac allograft vasculopathy
    Bellumkonda, Lavanya
    Patel, Jignesh
    CLINICAL TRANSPLANTATION, 2020, 34 (01)
  • [45] Optimal low-density lipoprotein concentration for cardiac allograft vasculopathy prevention
    Harris, Justin
    Teuteberg, Jeffery
    Shullo, Michael
    CLINICAL TRANSPLANTATION, 2018, 32 (05)
  • [46] Current Therapies for Cardiac Allograft Vasculopathy in Children
    Kindel, Steven J.
    Pahl, Elfriede
    CONGENITAL HEART DISEASE, 2012, 7 (04) : 324 - 335
  • [47] Failing to Make the Grade: Conventional Cardiac Allograft Rejection Grading Criteria Are Inadequate for Predicting Rejection Severity
    Arabyarmohammadi, Sara
    Yuan, Cai
    Viswanathan, Vidya Sankar
    Lal, Priti
    Feldman, Michael D.
    Fu, Pingfu
    Margulies, Kenneth B.
    Madabhushi, Anant
    Peyster, Eliot G.
    CIRCULATION-HEART FAILURE, 2024, 17 (02) : E010950
  • [48] Computed tomography imaging of cardiac allograft vasculopathy
    Ferencik, Maros
    Brady, Thomas J.
    Hoffmann, Udo
    JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY, 2012, 6 (04) : 223 - 231
  • [49] Circulating cytokine portraits can differentiate between allograft rejection and pulmonary infection in cardiac transplant rats
    Chen, Hao
    Li, Feng
    Zhan, Yanxia
    Yu, Weiyong
    Lu, Chen
    Cheng, Yunfeng
    Mei, Yunqing
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2016, 23 (01) : 118 - 124
  • [50] Cardiac Allograft Vasculopathy
    Lee, Michael S.
    Finch, Will
    Weisz, Giora
    Kirtane, Ajay J.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2011, 12 (03) : 143 - 152
12345